Results overview: Found 7 records in 0.02 seconds.
Articles, 7 records found
Articles 7 records found  
1.
2 p, 313.7 KB Correction to : The Small GTPase RAC1/CED-10 Is Essential in Maintaining Dopaminergic Neuron Function and Survival Against α-Synuclein-Induced Toxicity / Kim, Hanna (The University of Alabama. Department of Biological Sciences) ; Calatayud, Carles (Institut d'Investigació Biomèdica de Bellvitge) ; Guha, Sanjib (Buck Institute for Age Research) ; Fernandez Carasa, Irene (Universitat de Barcelona. Institut de Biomedicina) ; Berkowitz, Laura (University of Alabama. Department of Biological Sciences) ; Carballo-Carbajal, Iria (Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas) ; Ezquerra, Mario (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ; Fernández-Santiago, Rubén (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ; Kapahi, Pankaj (Buck Institute for Age Research) ; Raya, Ángel (Institució Catalana de Recerca i Estudis Avançats) ; Miranda Vizuete, Antonio (Instituto de Biomedicina de Sevilla) ; Lizcano de Vega, José Miguel (Universitat Autònoma de Barcelona. Departament de Bioquímica i de Biologia Molecular) ; Vila Bover, Miquel (Universitat Autònoma de Barcelona. Departament de Bioquímica i de Biologia Molecular) ; Caldwell, Kim A. (University of Alabama. Department of Biological Sciences) ; Caldwell, Guy A. (University of Alabama. Department of Biological Sciences) ; Consiglio, Antonella (Università degli Studi di Brescia. Dipartimento di Medicina Molecolare e Traslazionale) ; Dalfo, Esther (Universitat Autònoma de Barcelona. Institut de Neurociències)
2018 - 10.1007/s12035-018-1010-3
Molecular neurobiology, Vol. 55 (april 2018) , p. 7553-7554  
2.
11 p, 247.4 KB HLA and microtubule-associated protein tau H1 haplotype associations in anti-IgLON5 disease / Gaig, Carles (Hospital Clínic i Provincial de Barcelona) ; Ercilla, Guadalupe (Hospital Clínic i Provincial de Barcelona) ; Daura i Ribera, Xavier (Universitat Autònoma de Barcelona. Institut de Biotecnologia i de Biomedicina "Vicent Villar Palasí") ; Ezquerra, Mario (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ; Fernández-Santiago, Rubén (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ; Palou, Eduard (Hospital Clínic i Provincial de Barcelona) ; Sabater, Lidia (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ; Höftberger, Romana (Medical University of Vienna) ; Heidbreder, Anna (University Hospital Muenster (Alemanya)) ; Högl, Birgit (Medical University of Innsbruck) ; Iranzo, Alex (Hospital Clínic i Provincial de Barcelona) ; Santamaria, Joan (Hospital Clínic i Provincial de Barcelona) ; Dalmau, Josep (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ; Graus Ribas, Francesc (Institut d'Investigacions Biomèdiques August Pi i Sunyer)
We investigated the associations with HLA and microtubule-associated protein tau (MAPT) H1 haplotype in anti-IgLON5 disease, a recently identified disorder characterized by gait instability, brainstem dysfunction, and a prominent sleep disorder in association with IgLON5 antibodies and pathologic findings of a novel neuronal-specific tauopathy. [...]
2019 - 10.1212/NXI.0000000000000605
Neurology® neuroimmunology & neuroinflammation, Vol. 6, issue 6 (Nov. 2019)  
3.
14 p, 1.2 MB Advances in Parkinson's Disease : 200 Years Later / Del Rey, Natalia López-González (Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas) ; Quiroga-Varela, Ana (Department of Neuroscience, Centro de Investigación Médica Aplicada (CIMA), University of Navarra) ; Garbayo, Elisa (Instituto de Investigación Sanitaria de Navarra) ; Carballo-Carbajal, Iria (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Fernández-Santiago, Rubén (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ; Monje, Mariana H. G. (Universidad Autónoma de Madrid. Departamento de Anatomía, Histología y Neurociencia) ; Trigo-Damas, Inés (Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas) ; Blanco-Prieto, María J. (Instituto de Investigación Sanitaria de Navarra) ; Blesa, Javier (Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas) ; Universitat Autònoma de Barcelona
When James Parkinson described the classical symptoms of the disease he could hardly foresee the evolution of our understanding over the next two hundred years. Nowadays, Parkinson's disease is considered a complex multifactorial disease in which genetic factors, either causative or susceptibility variants, unknown environmental cues, and the potential interaction of both could ultimately trigger the pathology. [...]
2018 - 10.3389/fnana.2018.00113
Frontiers in Neuroanatomy, Vol. 12 (december 2018)  
4.
9 p, 1.2 MB Mitochondria function associated genes contribute to Parkinson's Disease risk and later age at onset / Billingsley, K. J. (National Institute on Aging (Estats Units d'Amèrica)) ; Barbosa, I. A. (King's College London) ; Bandrés-Ciga, S. (National Institute on Aging (Bethesda, Estats Units d'Amèrica)) ; Quinn, J. P. ; Bubb, V. J. ; Deshpande, C. (Clinical Genetics Unit. Guys and St. Thomas' NHS Foundation Trust) ; Botia, J. A. (Department of Neurodegenerative Disease. UCL Institute of Neurology) ; Reynolds, R. H. (Department of Neurodegenerative Disease. UCL Institute of Neurology) ; Zhang, D. (Department of Neurodegenerative Disease. UCL Institute of Neurology) ; Simpson, M. A. (King's College London) ; Blauwendraat, C. (National Institute on Aging (Bethesda, Estats Units d'Amèrica)) ; Gan-Or, Z. (Department of Human Genetics. McGill University) ; Gibbs, J. R. (National Institute on Aging (Bethesda, Estats Units d'Amèrica)) ; Nalls, M. A. (Data Tecnica International) ; Singleton, A. (National Institute on Aging (Bethesda, Estats Units d'Amèrica)) ; Noyce, A. (Preventive Neurology Unit. Wolfson Institute of Preventive Medicine. QMUL) ; Tucci, A. (UCL Institute of Neurology (Regne Unit). Department of Molecular Neuroscience) ; Middlehurst, B. ; Kia, D. (UCL Institute of Neurology (Regne Unit). Department of Molecular Neuroscience) ; Tan, M. (Department of Clinical Neuroscience. University College London) ; Houlden, H. (UCL Institute of Neurology (Regne Unit). Department of Molecular Neuroscience) ; Morris, H. R. (Department of Clinical Neuroscience. University College London) ; Plun-Favreau, H. (UCL Institute of Neurology (Regne Unit). Department of Molecular Neuroscience) ; Holmans, P. (MRC Centre for Neuropsychiatric Genetics & Genomics) ; Hardy, J. (UCL Institute of Neurology (Regne Unit). Department of Molecular Neuroscience) ; Trabzuni, D. (Department of Genetics. King Faisal Specialist Hospital and Research Centre) ; Bras, J. (UCL Institute of Neurology (Regne Unit). UK Dementia Research Institute) ; Mok, K. (UCL Institute of Neurology (Regne Unit). Department of Molecular Neuroscience) ; Kinghorn, K. (Institute of Healthy Ageing. University College London) ; Wood, N. (UCL Institute of Neurology (Regne Unit). Department of Molecular Neuroscience) ; Lewis, P. (University of Reading) ; Guerreiro, R. (UCL Institute of Neurology (Regne Unit). UK Dementia Research Institute) ; Lovering, R. (University College London) ; R'Bibo, L. (UCL Institute of Neurology (Regne Unit). Department of Molecular Neuroscience) ; Rizig, M. (UCL Institute of Neurology (Regne Unit). Department of Molecular Neuroscience) ; Escott-Price, V. (Cardiff University School of Medicine) ; Chelban, V. (UCL Institute of Neurology (Regne Unit). Department of Molecular Neuroscience) ; Foltynie, T. (Department of Neurodegenerative Disease. UCL Institute of Neurology) ; Williams, N. (Cardiff University School of Medicine) ; Brice, A. (Institut du Cerveau et de la Moelle épinière. ICM. Inserm U 1127. CNRS. UMR 7225. Sorbonne Universités. UPMC University Paris 06. UMR S 1127. AP-HP. Pitié-Salpêtrière Hospital) ; Danjou, F. (Institut du Cerveau et de la Moelle épinière. ICM. Inserm U 1127. CNRS. UMR 7225. Sorbonne Universités. UPMC University Paris 06. UMR S 1127. AP-HP. Pitié-Salpêtrière Hospital) ; Lesage, S. (Institut du Cerveau et de la Moelle épinière. ICM. Inserm U 1127. CNRS. UMR 7225. Sorbonne Universités. UPMC University Paris 06. UMR S 1127. AP-HP. Pitié-Salpêtrière Hospital) ; Martinez, M. (INSERM UMR 1220; and Paul Sabatier University) ; Giri, A. (DZNE. German Center for Neurodegenerative Diseases) ; Schulte, C. (DZNE. German Center for Neurodegenerative Diseases) ; Brockmann, K. (DZNE. German Center for Neurodegenerative Diseases) ; Simón-Sánchez, J. (DZNE. German Center for Neurodegenerative Diseases) ; Heutink, Peter (DZNE. German Center for Neurodegenerative Diseases) ; Rizzu, P. (DZNE. German Center for Neurodegenerative Diseases) ; Sharma, M. (Centre for Genetic Epidemiology. Institute for Clinical Epidemiology and Applied Biometry. University of Tubingen) ; Gasser, Thomas (DZNE. German Center for Neurodegenerative Diseases) ; Nicolas, A. (National Institute on Aging (Bethesda, Estats Units d'Amèrica)) ; Cookson, M. (National Institute on Aging (Bethesda, Estats Units d'Amèrica)) ; Faghri, F. (Department of Computer Science. University of Illinois at Urbana-Champaign) ; Hernández, Dena (National Institute on Aging (Bethesda, Estats Units d'Amèrica)) ; Shulman, J. (Jan and Dan Duncan Neurological Research Institute. Texas Children's Hospital) ; Robak, L. (Baylor College of Medicine) ; Lubbe, S. (Ken and Ruth Davee Department of Neurology. Northwestern University Feinberg School of Medicine) ; Finkbeiner, S. (Taube/Koret Center for Neurodegenerative Disease Research) ; Mencacci, N. (Northwestern University Feinberg School of Medicine) ; Lungu, C. (National Institutes of Health Division of Clinical Research. NINDS. National Institutes of Health) ; Scholz, S. (Neurodegenerative Diseases Research Unit. National Institute of Neurological Disorders and Stroke) ; Reed, X. (National Institute on Aging (Bethesda, Estats Units d'Amèrica)) ; Leonard, H. (National Institute on Aging (Bethesda, Estats Units d'Amèrica)) ; Rouleau, G. (Montreal Neurological Institute. McGill University) ; Krohan, L. (Department of Human Genetics. McGill University) ; van Hilten, J. (Department of Neurology. Leiden University Medical Center) ; Marinus, J. (Department of Neurology. Leiden University Medical Center) ; Adarmes-Gómez, A. D. (Hospital Universitario Virgen del Rocío (Sevilla, Andalusia)) ; Aguilar Barberà, Miquel (Hospital Universitari MútuaTerrassa) ; Álvarez Angulo, Iñaki (Hospital Universitari MútuaTerrassa) ; Alvarez, V. (Hospital Universitario Central de Asturias) ; Javier Barrero, F. (Hospital Universitario Parque Tecnologico de la Salud) ; Bergareche Yarza, J. (Biodonostia Osasun Ikerketako Institutura (País Basc)) ; Bernal-Bernal, I. (Hospital Universitario Virgen del Rocío (Sevilla, Andalusia)) ; Blazquez, M. (Hospital Universitario Central de Asturias) ; Bernal, M. B. T. (Hospital Universitario Virgen del Rocío (Sevilla, Andalusia)) ; Boungiorno, M. (Hospital Universitari MútuaTerrassa) ; Buiza-Rueda, D. (Hospital Universitario Virgen del Rocío (Sevilla, Andalusia)) ; Cámara, A. (Hospital Clínic i Provincial de Barcelona) ; Carcel, M. (Hospital Universitari MútuaTerrassa) ; Carrillo, F. (Hospital Universitario Virgen del Rocío (Sevilla, Andalusia)) ; Carrión-Claro, M. (Hospital Universitario Virgen del Rocío (Sevilla, Andalusia)) ; Cerdan, Debora (Hospital General de Segovia) ; Clarimón, Jordi (Institut d'Investigació Biomèdica Sant Pau) ; Compta, Yaroslau (Hospital Clínic i Provincial de Barcelona) ; Diez-Fairen, Monica. (Hospital Universitari MútuaTerrassa) ; Dols-Icardo, O. (Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas) ; Duarte, J. (Hospital General de Segovia) ; Duran, R. l. (Centro de Investigacion Biomedica. Universidad de Granada) ; Escamilla-Sevilla, F. (Instituto de Investigación Sanitaria de Granada) ; Ezquerra, M. (Hospital Clínic i Provincial de Barcelona) ; Fernández, M. (Hospital Clínic i Provincial de Barcelona) ; Fernández Santiago, Rubén (Hospital Clínic i Provincial de Barcelona) ; Garcia, C. (Hospital Universitario Central de Asturias) ; García-Ruiz, P. (Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz) ; Gómez-Garre, P. (Hospital Universitario Virgen del Rocío (Sevilla, Andalusia)) ; Heredia, M. G. (Hospital Universitario Virgen de la Victoria (Màlaga, Andalusia)) ; Gonzalez-Aramburu, I. (Instituto de Investigación Sanitaria Valdecilla (Santander, País Basc)) ; Pagola, A. G. (Biodonostia Osasun Ikerketako Institutura (País Basc)) ; Hoenicka, J. (Institut de Recerca Sant Joan de Déu) ; Infante, J. (Instituto de Investigación Sanitaria Valdecilla (Santander, País Basc)) ; Jesús, S. (Hospital Universitario Virgen del Rocío (Sevilla, Andalusia)) ; Jimenez-Escrig, A. (Hospital Universitario Ramón y Cajal (Madrid)) ; Kulisevsky, J. (Institut d'Investigació Biomèdica Sant Pau) ; Labrador-Espinosa, M. (Hospital Universitario Virgen del Rocío (Sevilla, Andalusia)) ; Lopez-Sendon, J. (Hospital Universitario Ramón y Cajal (Madrid)) ; de Munain Arregui, A. L. (Hospital Universitario Ramón y Cajal (Madrid)) ; Macías-García, Daniel (Hospital Universitario Virgen del Rocío (Sevilla, Andalusia)) ; Torres, I. M. (Hospital Universitari i Politècnic La Fe de València) ; Marín, J. (Institut d'Investigació Biomèdica Sant Pau) ; Marti, M. J. (Hospital Clínic i Provincial de Barcelona) ; Martínez-Castrillo, J. (Hospital Universitario Ramón y Cajal (Madrid)) ; Méndez-del-Barrio, C. (Hospital Universitario Virgen del Rocío (Sevilla, Andalusia)) ; Menéndez González, M. (Hospital Universitario Virgen del Rocío (Sevilla, Andalusia)) ; Mínguez, A. (Instituto de Investigación Sanitaria de Granada) ; Mir, P. (Hospital Universitario Virgen del Rocío (Sevilla, Andalusia)) ; Rezola, E. M. (Biodonostia Osasun Ikerketako Institutura (País Basc)) ; Muñoz García, José Esteban (Hospital Clínic i Provincial de Barcelona) ; Pagonabarraga, J. (Institut d'Investigació Biomèdica Sant Pau) ; Pastor, Pau (Hospital Universitari MútuaTerrassa) ; Errazquin, F. P. (Hospital Universitario Virgen de la Victoria (Màlaga, Andalusia)) ; Periñán-Tocino, T. (Hospital Universitario Virgen del Rocío (Sevilla, Andalusia)) ; Ruiz-Martínez, J. (Biodonostia Osasun Ikerketako Institutura (País Basc)) ; Ruz, C. (Centro de Investigacion Biomedica. Universidad de Granada) ; Rodriguez, A. S. (Instituto de Investigación Sanitaria Valdecilla (Santander, País Basc)) ; Sierra, M. (Instituto de Investigación Sanitaria Valdecilla (Santander, País Basc)) ; Suarez-Sanmartin, E. (Clinical Genetics Unit. Guys and St. Thomas' NHS Foundation Trust) ; Tabernero, C. (Hospital Universitario Ramón y Cajal (Madrid)) ; Tartari, J. P. (Hospital Universitari MútuaTerrassa) ; Tejera-Parrado, C. (Hospital Universitario Virgen del Rocío (Sevilla, Andalusia)) ; Tolosa, E. (Hospital Clínic i Provincial de Barcelona) ; Valldeoriola, F. (Hospital Clínic i Provincial de Barcelona) ; Vargas-González, L. (Hospital Universitario Virgen del Rocío (Sevilla, Andalusia)) ; Vela, L. (Hospital Universitario Fundación Alcorcón) ; Vives, F. (Centro de Investigacion Biomedica. Universidad de Granada) ; Zimprich, Alexander (Department of Neurology. Medical University of Vienna) ; Pihlstrom, L. (Oslo University Hospital (Oslo, Noruega)) ; Taba, P. (Department of Neurology and Neurosurgery. University of Tartu) ; Majamaa, K. (Oulu University Hospital. (Finlàndia)) ; Siitonen, A. (Institute of Clinical Medicine. Department of Neurology. University of Oulu) ; Okubadejo, N. (University of Lagos) ; Ojo, O. (University of Lagos) ; Ryten, Mina (Department of Neurodegenerative Disease. UCL Institute of Neurology) ; Koks, S. (Centre for Comparative Genomics. Murdoch University) ; Universitat Autònoma de Barcelona
Mitochondrial dysfunction has been implicated in the etiology of monogenic Parkinson's disease (PD). Yet the role that mitochondrial processes play in the most common form of the disease; sporadic PD, is yet to be fully established. [...]
2019 - 10.1038/s41531-019-0080-x
NPJ Parkinson's disease, Vol. 5 Núm. 1 (january 2019) , p. 8  
5.
14 p, 2.8 MB Moving beyond neurons : the role of cell type-specific gene regulation in Parkinson's disease heritability / Reynolds, R. H. (Department of Neurodegenerative Disease. University College London (UCL) Institute of Neurology) ; Botía, J. (Universidad de Murcia. Departamento de Ingeniería de la Información y las Comunicaciones) ; Nalls, M. A. (Data Tecnica International) ; Noyce, A. J. (Preventive Neurology Unit. Wolfson Institute of Preventive Medicine. QMUL) ; Nicolas, A. (National Institute on Aging (Estats Units d'Amèrica)) ; Cookson, M. R. (National Institute on Aging (Estats Units d'Amèrica)) ; Bandres-Ciga, S. (National Institute on Aging (Estats Units d'Amèrica)) ; Gibbs, J. R. (National Institute on Aging (Estats Units d'Amèrica)) ; Hernandez, D. G. (National Institute on Aging (Estats Units d'Amèrica)) ; Singleton, A. B. (National Institute on Aging (Estats Units d'Amèrica)) ; Reed, X. (National Institute on Aging (Estats Units d'Amèrica)) ; Leonard, H. (National Institute on Aging (Estats Units d'Amèrica)) ; Blauwendraat, C. (National Institute of Neurological Disorders and Stroke) ; Faghri, F. (Department of Computer Science. University of Illinois at Urbana-Champaign) ; Bras, J. (Department of Molecular Neuroscience. UCL) ; Guerreiro, R. (Department of Molecular Neuroscience. UCL) ; Tucci, A. (Department of Molecular Neuroscience. UCL) ; Kia, D. A. (Department of Molecular Neuroscience. UCL) ; Houlden, H. (Department of Molecular Neuroscience. UCL) ; Plun-Favreau, H. (Department of Molecular Neuroscience. UCL) ; Mok, K. Y. (Department of Molecular Neuroscience. UCL) ; Wood, N. W. (Department of Molecular Neuroscience. UCL) ; Lovering, R. (Department of Molecular Neuroscience. UCL) ; R'Bibo, L. (Department of Molecular Neuroscience. UCL) ; Rizig, M. (Department of Molecular Neuroscience. UCL) ; Chelban, V. (Department of Molecular Neuroscience. UCL) ; Trabzuni, D. (Department of Genetics. King Faisal Specialist Hospital and Research Centre) ; Tan, M. (Department of Clinical Neuroscience. University College London) ; Morris, H. R. (Department of Clinical Neuroscience. University College London) ; Middlehurst, B. (Institute of Translational Medicine. University of Liverpool) ; Quinn, J. (Institute of Translational Medicine. University of Liverpool) ; Billingsley, K. (Institute of Translational Medicine. University of Liverpool) ; Holmans, P. (MRC Centre for Neuropsychiatric Genetics & Genomics) ; Kinghorn, K. J. (Institute of Healthy Ageing. University College London) ; Lewis, P. (University of Reading) ; Escott-Price, V. (MRC Centre for Neuropsychiatric Genetics and Genomics. Cardiff University School of Medicine) ; Williams, N. (MRC Centre for Neuropsychiatric Genetics and Genomics. Cardiff University School of Medicine) ; Foltynie, T. (UCL Institute of Neurology (Regne Unit)) ; Brice, A. (Institut du Cerveau et de la Moelle épinière. ICM. Inserm U 1127. CNRS. UMR 7225. Sorbonne Universités. UPMC University Paris 06. UMR S 1127. AP-HP. Pitié-Salpêtrière Hospital) ; Danjou, F. (Institut du Cerveau et de la Moelle épinière. ICM. Inserm U 1127. CNRS. UMR 7225. Sorbonne Universités. UPMC University Paris 06. UMR S 1127. AP-HP. Pitié-Salpêtrière Hospital) ; Lesage, S. (Institut du Cerveau et de la Moelle épinière. ICM. Inserm U 1127. CNRS. UMR 7225. Sorbonne Universités. UPMC University Paris 06. UMR S 1127. AP-HP. Pitié-Salpêtrière Hospital) ; Corvol, Jean-Christophe (Institut du Cerveau et de la Moelle épinière. ICM. Inserm U 1127. CNRS. UMR 7225. Sorbonne Universités. UPMC University Paris 06. UMR S 1127. AP-HP. Pitié-Salpêtrière Hospital) ; Martinez, M. (Paul Sabatier University) ; Giri, A. (DZNE. German Center for Neurodegenerative Diseases) ; Schulte, C. (DZNE. German Center for Neurodegenerative Diseases) ; Brockmann, K. (DZNE. German Center for Neurodegenerative Diseases) ; Simón-Sánchez, J. (DZNE. German Center for Neurodegenerative Diseases) ; Heutink, Peter (DZNE. German Center for Neurodegenerative Diseases) ; Gasser, Thomas (DZNE. German Center for Neurodegenerative Diseases) ; Rizzu, P. (DZNE. German Center for Neurodegenerative Diseases) ; Sharma, M. (Centre for Genetic Epidemiology. Institute for Clinical Epidemiology and Applied Biometry. University of Tubingen) ; Shulman, J. M. (Jan and Dan Duncan Neurological Research Institute. Texas Children's Hospital) ; Robak, L. (Departments of Neurology. Neuroscience. and Molecular & Human Genetics. Baylor College of Medicine) ; Lubbe, S. (Ken and Ruth Davee Department of Neurology. Northwestern University Feinberg School of Medicine) ; Mencacci, N. E. (Northwestern University Feinberg School of Medicine) ; Finkbeiner, S. (Gladstone Institute of Neurological Disease. Taube/Koret Center for Neurodegenerative Disease Research) ; Lungu, C. (National Institutes of Health Division of Clinical Research. NINDS. National Institutes of Health) ; Scholz, S. W. (Neurodegenerative Diseases Research Unit. National Institute of Neurological Disorders and Stroke) ; Gan-Or, Z. (Montreal Neurological Institute and Hospital. Departments of Neurology and Neurosurgery. Department of Human Genetics. McGill University) ; Rouleau, G. A. (Montreal Neurological Institute and Hospital. Departments of Neurology and Neurosurgery. Department of Human Genetics. McGill University) ; Krohan, L. (Department of Human Genetics. McGill University) ; van Hilten, J. J. (Department of Neurology. Leiden University Medical Center) ; Marinus, J. (Department of Neurology. Leiden University Medical Center) ; Adarmes-Gómez, A. D. (Hospital Universitario Virgen del Rocío (Sevilla, Andalusia)) ; Bernal-Bernal, I. (Hospital Universitario Virgen del Rocío (Sevilla, Andalusia)) ; Bonilla-Toribio, M. (Hospital Universitario Virgen del Rocío (Sevilla, Andalusia)) ; Buiza-Rueda, D. (Hospital Universitario Virgen del Rocío (Sevilla, Andalusia)) ; Carrillo, F. (Hospital Universitario Virgen del Rocío (Sevilla, Andalusia)) ; Carrión-Claro, M. (Hospital Universitario Virgen del Rocío (Sevilla, Andalusia)) ; Mir, P. (Hospital Universitario Virgen del Rocío (Sevilla, Andalusia)) ; Gómez-Garre, P. (Hospital Universitario Virgen del Rocío (Sevilla, Andalusia)) ; Jesús, S. (Hospital Universitario Virgen del Rocío (Sevilla, Andalusia)) ; Labrador-Espinosa, M. A. (Hospital Universitario Virgen del Rocío (Sevilla, Andalusia)) ; Macías-García, Daniel (Hospital Universitario Virgen del Rocío (Sevilla, Andalusia)) ; Vargas-González, L. (Hospital Universitario Virgen del Rocío (Sevilla, Andalusia)) ; Méndez-del-Barrio, C. (Hospital Universitario Virgen del Rocío (Sevilla, Andalusia)) ; Periñán-Tocino, T. (Hospital Universitario Virgen del Rocío (Sevilla, Andalusia)) ; Tejera-Parrado, C. (Hospital Universitario Virgen del Rocío (Sevilla, Andalusia)) ; Diez-Fairen, Monica. (Hospital Universitari MútuaTerrassa) ; Aguilar Barberà, Miquel (Hospital Universitari MútuaTerrassa) ; Álvarez Angulo, Iñaki (Hospital Universitari MútuaTerrassa) ; Boungiorno, M. T. (Hospital Universitari MútuaTerrassa) ; Carcel, M. (Hospital Universitari MútuaTerrassa) ; Pastor, Pau (Hospital Universitari MútuaTerrassa) ; Tartari, J. P. (Hospital Universitari MútuaTerrassa) ; Alvarez, V. (Hospital Universitario Central de Asturias) ; González, M. M. (Hospital Universitario Central de Asturias) ; Blazquez, M. (Hospital Universitario Central de Asturias) ; Garcia, C. (Hospital Universitario Central de Asturias) ; Suarez-Sanmartin, E. (Hospital Universitario Central de Asturias) ; Barrero, F. J. (Hospital Universitario Parque Tecnologico de la Salud) ; Rezola, E. M. (Biodonostia Osasun Ikerketako Institutura (País Basc)) ; Yarza, J. A. B. (Biodonostia Osasun Ikerketako Institutura (País Basc)) ; Pagola, A. G. (Biodonostia Osasun Ikerketako Institutura (País Basc)) ; de Munain Arregui, A. L. (Biodonostia Osasun Ikerketako Institutura (País Basc)) ; Ruiz-Martínez, J. (Biodonostia Osasun Ikerketako Institutura (País Basc)) ; Cerdan, D. (Hospital General de Segovia) ; Duarte, J. (Hospital General de Segovia) ; Clarimón, Jordi (Institut d'Investigació Biomèdica Sant Pau) ; Dols-Icardo, O. (Institut d'Investigació Biomèdica Sant Pau) ; Infante, J. (University of Cantabria) ; Marín, J. (Institut d'Investigació Biomèdica Sant Pau) ; Kulisevsky, J. (Institut d'Investigació Biomèdica Sant Pau) ; Pagonabarraga, J. (Institut d'Investigació Biomèdica Sant Pau) ; Gonzalez-Aramburu, I. (Instituto de Investigación Sanitaria Valdecilla (Santander, País Basc)) ; Rodriguez, A. S. (Instituto de Investigación Sanitaria Valdecilla (Santander, País Basc)) ; Sierra, M. (Instituto de Investigación Sanitaria Valdecilla (Santander, País Basc)) ; Duran, R. (Centro de Investigacion Biomedica. Universidad de Granada) ; Ruz, C. (Centro de Investigacion Biomedica. Universidad de Granada) ; Vives, F. (Centro de Investigacion Biomedica. Universidad de Granada) ; Escamilla-Sevilla, F. (Instituto de Investigación Sanitaria de Granada) ; Mínguez, A. (Instituto de Investigación Sanitaria de Granada) ; Cámara, A. (Hospital Clínic i Provincial de Barcelona) ; Compta, Yaroslau (Hospital Clínic i Provincial de Barcelona) ; Ezquerra, M. (Hospital Clínic i Provincial de Barcelona) ; Marti, M. J. (Hospital Clínic i Provincial de Barcelona) ; Fernández, M. (Hospital Clínic i Provincial de Barcelona) ; Muñoz García, José Esteban (Hospital Clínic i Provincial de Barcelona) ; Fernández Santiago, Rubén (Hospital Clínic i Provincial de Barcelona) ; Tolosa, E. (Hospital Clínic i Provincial de Barcelona) ; Valldeoriola, F. (Hospital Clínic i Provincial de Barcelona) ; García-Ruiz, P. (Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz) ; Heredia, M. J. G. (Hospital Universitario Virgen de la Victoria (Màlaga, Andalusia)) ; Errazquin, F. P. (Hospital Universitario Virgen de la Victoria (Màlaga, Andalusia)) ; Hoenicka, J. (Institut de Recerca Sant Joan de Déu) ; Jimenez-Escrig, A. (Hospital Universitario Ramón y Cajal (Madrid)) ; Martínez-Castrillo, J. C. (Hospital Universitario Ramón y Cajal (Madrid)) ; Lopez-Sendon, J. L. (Hospital Universitario Ramón y Cajal (Madrid)) ; Torres, I. M. (Hospital Universitari i Politècnic La Fe de València) ; Tabernero, C. (Hospital General de Segovia) ; Vela, L. (Hospital Universitario Fundación Alcorcón) ; Zimprich, Alexander (Department of Neurology. Medical University of Vienna) ; Pihlstrom, L. (Oslo University Hospital (Oslo, Noruega)) ; Koks, S. (Perron Institute for Neurological and Translational Science) ; Taba, P. (Departments of Neurology and Neurosurgery. University of Tartu) ; Majamaa, K. (Oulu University Hospital. (Finlàndia)) ; Siitonen, A. (Oulu University Hospital. (Finlàndia)) ; Okubadejo, N. U. (University of Lagos) ; Ojo, O. O. (University of Lagos) ; Pitcher, T. (Department of Medicine. University of Otago) ; Anderson, T. (Department of Medicine. University of Otago) ; Bentley, S. (Griffith Institute for Drug Discovery. Griffith University) ; Fowdar, J. (Griffith Institute for Drug Discovery. Griffith University) ; Mellick, G. (Griffith Institute for Drug Discovery. Griffith University) ; Dalrymple-Alford, J. (Department Psychology. University of Canterbury. New Zealand Brain Research Institute) ; Henders, A. K. (Institute for Molecular Bioscience. University of Queensland) ; Kassam, I. (Institute for Molecular Bioscience. University of Queensland) ; Montgomery, G. (Institute for Molecular Bioscience. University of Queensland) ; Sidorenko, J. (Institute for Molecular Bioscience. University of Queensland) ; Zhang, F. (Institute for Molecular Bioscience. University of Queensland) ; Xue, A. (Institute for Molecular Bioscience. University of Queensland) ; Vallerga, C. L. (Institute for Molecular Bioscience. University of Queensland) ; Wallace, Leanne (Institute for Molecular Bioscience. University of Queensland) ; Wray, N. R. (Queensland Brain Institute. University of Queensland) ; Yang, J. (Queensland Brain Institute. University of Queensland) ; Visscher, P. M. (Queensland Brain Institute. University of Queensland) ; Gratten, J. (Queensland Brain Institute. University of Queensland) ; Silburn, P. A. (Queensland Brain Institute. University of Queensland) ; Halliday, G. (University of Sydney. Brain and Mind Centre) ; Hickie, I. B. (University of Sydney. Brain and Mind Centre) ; Kwok, J. (University of Sydney. Brain and Mind Centre) ; Lewis, S. (University of Sydney. Brain and Mind Centre) ; Kennedy, M. (Department of Pathology. University of Otago) ; Pearson, J. (Department of Pathology. University of Otago) ; Hardy, J. (UK Dementia Research Institute at University College London (UCL)) ; Gagliano Taliun, S. A. (Center for Statistical Genetics and Department of Biostatistics. University of Michigan) ; Ryten, Mina (Department of Neurodegenerative Disease. University College London (UCL) Institute of Neurology) ; Universitat Autònoma de Barcelona
Parkinson's disease (PD), with its characteristic loss of nigrostriatal dopaminergic neurons and deposition of α-synuclein in neurons, is often considered a neuronal disorder. However, in recent years substantial evidence has emerged to implicate glial cell types, such as astrocytes and microglia. [...]
2019 - 10.1038/s41531-019-0076-6
NPJ Parkinson's disease, Vol. 5 Núm. 1 (january 2019) , p. 6  
6.
20 p, 8.2 MB The small GTPase RAC1/CED-10 is essential in maintaining dopaminergic neuron function and survival against α-synuclein-induced toxicity / Kim, Hanna (University of Alabama. Department of Biological Sciences) ; Calatayud, Carles (Institut d'Investigació Biomèdica de Bellvitge) ; Guha, Sanjib (Buck Institute for Age Research) ; Fernandez Carasa, Irene (Universitat de Barcelona. Institut de Biomedicina) ; Berkowitz, Laura (University of Alabama. Department of Biological Sciences) ; Carballo-Carbajal, Iria (Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas) ; Ezquerra, Mario (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ; Fernández-Santiago, Rubén (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ; Kapahi, Pankaj (Buck Institute for Age Research) ; Raya, Ángel (Institució Catalana de Recerca i Estudis Avançats) ; Miranda Vizuete, Antonio (Instituto de Biomedicina de Sevilla) ; Lizcano de Vega, José Miguel (Universitat Autònoma de Barcelona. Departament de Bioquímica i de Biologia Molecular) ; Vila Bover, Miquel (Universitat Autònoma de Barcelona. Departament de Bioquímica i de Biologia Molecular) ; Caldwell, Kim A. (University of Alabama. Department of Biological Sciences) ; Caldwell, Guy A. (University of Alabama. Department of Biological Sciences) ; Consiglio, Antonella (Università degli Studi di Brescia. Dipartimento di Medicina Molecolare e Traslazionale) ; Dalfo, Esther (Universitat Autònoma de Barcelona. Departament de Bioquímica i de Biologia Molecular)
Parkinson's disease is associated with intracellular α-synuclein accumulation and ventral midbrain dopaminergic neuronal death in the Substantia Nigra of brain patients. The Rho GTPase pathway, mainly linking surface receptors to the organization of the actin and microtubule cytoskeletons, has been suggested to participate to Parkinson's disease pathogenesis. [...]
2018 - 10.1007/s12035-018-0881-7
Molecular neurobiology, Vol. 55, issue 9 (Sep. 2018) , p. 7533-7552  
7.
18 p, 2.2 MB Aberrant epigenome in -derived dopaminergic neurons from Parkinson's disease patients / Fernández-Santiago, Rubén (Universitat de Barcelona) ; Carballo-Carbajal, Iria (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Castellano, Giancarlo (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ; Torrent, Roger (Universitat de Barcelona. Institut de Biomedicina) ; Richaud, Yvonne (Centro de Investigación Biomédica en Red de Bioingeniería, Biomateriales y Nanomedicina) ; Sánchez-Danés, Adriana (Universitat de Barcelona. Institut de Biomedicina) ; Vilarrasa-Blasi, Roser (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ; Sánchez-Pla, Alex (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Mosquera, José Luis (Universitat de Barcelona) ; Soriano, Jordi (Universitat de Barcelona) ; López-Barneo, José (Hospital Universitario Virgen del Rocío (Sevilla, Andalusia)) ; Canals, Josep M. (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ; Alberch i Vié, Jordi (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ; Raya, Ángel (Institució Catalana de Recerca i Estudis Avançats) ; Vila Bover, Miquel (Hospital Universitari Vall d'Hebron. Institut de Recerca) ; Consiglio, Antonella (University of Brescia and National Institute of Neuroscience) ; Martín-Subero, José I (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ; Ezquerra, Mario (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ; Tolosa, Eduardo (Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas) ; Universitat Autònoma de Barcelona
The epigenomic landscape of Parkinson's disease () remains unknown. We performed a genomewide methylation and a transcriptome studies in induced pluripotent stem cell ()-derived dopaminergic neurons (n) generated by cell reprogramming of somatic skin cells from patients with monogenic 2-associated (L2) or sporadic (), and healthy subjects. [...]
2015 - 10.15252/emmm.201505439
EMBO Molecular Medicine, Vol. 7, Núm. 12 (October 2015) , p. 1529-1546  

See also: similar author names
2 Fernández-Santiago, R.
5 Fernández-Santiago, Ruben
Interested in being notified about new results for this query?
Set up a personal email alert or subscribe to the RSS feed.